Esperion Therapeutics, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Esperion Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Esperion Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -27.9 %, a 68% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2023 was -91.6 %, a 18.4% decline from 2022.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2022 was -77.4 %, a 16.2% increase from 2021.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2021 was -92.3 %, a 79.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -91.6 -14.2 -18.4% Jan 1, 2023 Dec 31, 2023
2022 -77.4 +14.9 +16.2% Jan 1, 2022 Dec 31, 2022
2021 -92.3 -40.8 -79.2% Jan 1, 2021 Dec 31, 2021
2020 -51.5 -13.2 -34.6% Jan 1, 2020 Dec 31, 2020
2019 -38.3 +66.2 +63.4% Jan 1, 2019 Dec 31, 2019
2018 -104 -37.1 -55% Jan 1, 2018 Dec 31, 2018
2017 -67.4 -39.5 -141% Jan 1, 2017 Dec 31, 2017
2016 -28 -11.9 -74.5% Jan 1, 2016 Dec 31, 2016
2015 -16 +26.4 +62.2% Jan 1, 2015 Dec 31, 2015
2014 -42.4 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.